US Stock MarketDetailed Quotes

XFOR X4 Pharmaceuticals

Watchlist
  • 0.611
  • +0.004+0.66%
Close Dec 20 16:00 ET
  • 0.640
  • +0.029+4.69%
Post 20:01 ET
104.26MMarket Cap-7.64P/E (TTM)

X4 Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

X4 Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.69M
560.00K
-1.13M
Miss Est.
--
--
-66.79%
EPS
-0.17
-0.18
-<0.01
Miss Est.
-1645.45%
-1700.00%
-4.17%
Analyst Rating
Buy

Dec 8, 2024

X4 Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.526M--
--2024/Q4-- / 1.065M--
Nov 13, 20242024/Q3560.000K / 1.686M--
Aug 8, 20242024/Q2563.000K / 15.265M--
May 7, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.526M--
--2024/Q4-- / 1.065M--
Nov 13, 20242024/Q3560.000K / 1.686M--
Aug 8, 20242024/Q2563.000K / 15.265M--
May 7, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

X4 Pharmaceuticals Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 13 22:08

  • 8-K: X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 13 19:17

  • 10-Q: Q2 2024 Earnings Report

    Aug 9 04:15

  • 8-K: X4 Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

    Aug 8 18:44

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 8, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data